NCT00111553
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis No drug interventions treatment 1 completed NCT03303898
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE - No drug interventions other Not Available completed NCT03445897
Miltefosine Plus IL Pentamidine for Bolivian CL treatment 2 completed NCT00480883
Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol treatment Not Available completed NCT03294161
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis treatment 2 completed NCT03762070
Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru No drug interventions Not Available Not Available unknown_status NCT05708625
Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis treatment 3 recruiting NCT04888130
Investigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (CEFELEISH) No drug interventions Not Available Not Available completed NCT04072874
Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis. No drug interventions treatment 1 / 2 withdrawn NCT01140191
Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis treatment 2 terminated NCT00469495
Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis treatment Not Available completed NCT03999970
A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol No drug interventions other Not Available completed NCT03969134
A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL No drug interventions treatment 2 completed NCT01641796
Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis Not Available Not Available no_longer_available NCT00508963
Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis Not Available Not Available no_longer_available NCT04841239
Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis No drug interventions treatment Not Available completed NCT03096457
Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia treatment 2 / 3 completed NCT01032382
Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) treatment 2 completed NCT01083576
Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama treatment 2 completed NCT05094908
Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis treatment 1 recruiting NCT02894008
A Study of a New Leishmania Vaccine Candidate ChAd63-KH No drug interventions treatment 2 completed NCT02979002
Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco No drug interventions Not Available Not Available completed NCT00344084
Surveillance for Leishmaniasis Skin Lesions in Mali No drug interventions Not Available Not Available completed NCT03023111
Miltefosine and GM-CSF in Cutaneous Leishmaniasis treatment 3 completed NCT01011309
A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis treatment 2 completed NCT00840359
Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis No drug interventions treatment 2 unknown_status NCT01790659
Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama treatment 3 completed NCT01300975
Intralesional Antimony for Bolivian Cutaneous Leishmaniasis treatment 2 completed NCT00703924
Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World treatment 2 completed NCT01661296
Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India treatment 4 completed NCT00737386
Frequency of Parasite Infection in Hyraxes and Sandflies During Outbreak of Leishmania Tropica Epidemic in The West Bank No drug interventions Not Available Not Available unknown_status NCT00351520
Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica No drug interventions treatment 3 completed NCT01845727
Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia treatment 1 / 2 completed NCT00606580
Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) treatment 3 completed NCT00317629
Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis treatment 3 terminated NCT01380301
Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony treatment 2 terminated NCT01494350
WR 279,396 Open Label Treatment Protocol in Tunisia treatment 2 terminated NCT00487253
Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia treatment 3 unknown_status NCT00884377
Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis treatment 2 completed NCT01050777
Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis supportive_care 0 completed NCT00233545
Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia treatment 2 completed NCT00471705
Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia. treatment 3 completed NCT04699383
Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia Not Available Not Available completed NCT00973128
Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis treatment 2 completed NCT04340128
Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL) treatment 3 completed NCT02687971
Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨ treatment 2 completed NCT01050907
Miltefosine to Treat Mucocutaneous Leishmaniasis treatment 2 completed NCT00633009
Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen No drug interventions screening 2 completed NCT01988909
WR 279,396 for the Treatment of Cutaneous Leishmaniasis No drug interventions treatment 2 completed NCT00682656
Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis treatment 2 / 3 terminated NCT01462500
Pharmacokinetics of Miltefosine in Children and Adults treatment 4 completed NCT01464242
Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis treatment 2 / 3 completed NCT00001906
Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants treatment 1 completed NCT00121849
Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite No drug interventions prevention 1 completed NCT00657917
Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396 treatment 2 terminated NCT01301924
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis treatment 2 / 3 completed NCT01277796
Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis No drug interventions Not Available Not Available available NCT00257530
Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis treatment 3 completed NCT00490230
Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application No drug interventions Not Available Not Available completed NCT00121862
Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite No drug interventions prevention 2 completed NCT00317980
Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis treatment 4 completed NCT01953744
High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus treatment 3 terminated NCT02281669
Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients Not Available Not Available unknown_status NCT01380314
Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis treatment 2 completed NCT01381055
Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis treatment 2 / 3 completed